Showing 3,961 - 3,980 results of 4,182 for search '"Pulmonology"', query time: 0.10s Refine Results
  1. 3961
  2. 3962

    Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary C... by Czira A, Requena G, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS

    Published 2023-04-01
    “…Alexandrosz Czira,1 Gema Requena,1 Victoria Banks,2 Robert Wood,2 Theo Tritton,2 Catherine M Castillo,2 Jie Yeap,2 Rosie Wild,2 Chris Compton,1 Kieran J Rothnie,1 Felix Herth,3,4 Jennifer K Quint,5 Afisi S Ismaila6,7 1R&D Global Medical, GSK, Brentford, Middlesex, UK; 2Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK; 3Department of Pulmonology and Respiratory Care Medicine, Thoraxklinik at the University of Heidelberg, Heidelberg, Germany; 4Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research DZL, Heidelberg, Germany; 5National Heart and Lung Institute, Imperial College London, London, UK; 6Value Evidence and Outcomes, GSK, Collegeville, PA, USA; 7Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, CanadaCorrespondence: Alexandrosz Czira, Value Evidence and Outcomes, R&D Global Medical, GSK, Brentford, Middlesex, UK, Tel +44 7788 351610, Email alexandrosz.x.czira@gsk.comPurpose: To compare adherence to once-daily umeclidinium/vilanterol (UMEC/VI), a long-acting muscarinic antagonist/long-acting β2-agonist (LAMA/LABA), and twice-daily inhaled corticosteroids (ICS)/LABA single-inhaler dual therapy in patients with chronic obstructive pulmonary disease (COPD) in a primary care cohort in England.Patients and Methods: Active comparator, new-user, retrospective cohort study using CPRD-Aurum primary care data and linked Hospital Episode Statistics secondary care administrative data. …”
    Get full text
    Article
  3. 3963
  4. 3964
  5. 3965

    The ARISCAT Risk Index as a Predictor of Pulmonary Complications After Thoracic Surgeries, Almoosa Specialist Hospital, Saudi Arabia by Eldaabossi S, Al-Ghoneimy Y, Ghoneim A, Awad A, Mahdi W, Farouk A, Soliman H, Kanany H, Antar A, Gaber Y, Shaarawy A, Nabawy O, Atef M, Nour SO, Kabil A

    Published 2023-03-01
    “…Safwat Eldaabossi,1,2 Yasser Al-Ghoneimy,3 Ayman Ghoneim,3,4 Amgad Awad,5,6 Waheed Mahdi,2– 7 Abdallah Farouk,8,9 Hesham Soliman,10 Hatem Kanany,11 Ahmad Antar,12 Yasser Gaber,13,14 Ahmed Shaarawy,1 Osama Nabawy,1 Moaz Atef,1 Sameh O Nour,1 Ahmed Kabil1 1Department of Chest Diseases, Al-Azhar University, Cairo, Egypt; 2Pulmonology Department, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia; 3Cardiothoracic Surgery Department, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia; 4Department of Cardiothoracic Surgery, Al-Azhar University, Cairo, Egypt; 5Nephrology Department, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia; 6Department of Internal Medicine, Al-Azhar University, Cairo, Egypt; 7Department of Chest Diseases, Banha Faculty of Medicine, Banha, Egypt; 8Critical Care Consultant, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia; 9Department of Critical Care, Alexandria Faculty of Medicine, Alexandria, Egypt; 10Consultant and Chief of Anesthesia, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia; 11Department of Critical Care and Anesthesia, Al-Azhar University, Cairo, Egypt; 12Department of Internal Medicine, Hematology-Oncology Section, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia; 13Radiology Department, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia; 14Department of Radiology, Al-Azhar University, Cairo, EgyptCorrespondence: Ahmed Kabil, Department of Chest Diseases, Al-Azhar University, Cairo, Egypt, Tel +201006396601, Email a_ka_81@hotmail.comBackground: Pulmonary complications after thoracic surgery are common and are associated with prolonged hospital stay, higher costs, and increased mortality. …”
    Get full text
    Article
  6. 3966
  7. 3967
  8. 3968

    Post-Severe-COVID-19 Cardiopulmonary Rehabilitation: A Comprehensive Study on Patient Features and Recovery Dynamics in Correlation with Workout Intensity by Andreea Dumitrescu, Gabriela Doros, Voichita Elena Lazureanu, Susa Septimiu-Radu, Felix Bratosin, Ovidiu Rosca, Harshkumar Patel, Tamara Mirela Porosnicu, Gabriela Mut Vitcu, Andrei Mirea, Cristian Oancea, Stefan Mihaicuta, Emil Robert Stoicescu, Paula Irina Barata

    Published 2023-06-01
    “…Conducted between September 2021 and September 2022, this prospective study included patients who had been diagnosed with severe COVID-19 and admitted at the “Victor Babes” Infectious Diseases and Pulmonology Hospital, Timisoara, Romania. The patients were stratified into low- and high-intensity rehabilitation groups. …”
    Get full text
    Article
  9. 3969
  10. 3970
  11. 3971
  12. 3972
  13. 3973
  14. 3974

    Bacterial and Fungal Superinfections in COVID-19 Patients Hospitalized in an Intensive Care Unit from Timișoara, Romania by Novacescu AN, Buzzi B, Bedreag O, Papurica M, Rogobete AF, Sandesc D, Sorescu T, Baditoiu L, Musuroi C, Vlad D, Licker M

    Published 2022-12-01
    “…Victor Babes’ Infectious Diseases and Pulmonology Clinical Hospital, Timisoara, Romania; 3Clinic of Anesthesia and Intensive Care, ‘Pius Brînzeu’ Emergency Clinical County Hospital, Timisoara, Romania; 4Department of Anaesthesia and Intensive Care, ‘Victor Babes’ University of Medicine and Pharmacy, Timisoara, Romania; 5Department of Diabetes, Nutrition and Metabolic Diseases, ‘Victor Babes’ University of Medicine and Pharmacy, Timisoara, Romania; 6Clinic of Diabetes, Nutrition and Metabolic Diseases, ‘Pius Brînzeu’ Emergency Clinical County Hospital, Timisoara, Romania; 7Department of Epidemiology, “Victor Babes” University of Medicine and Pharmacy, Timisoara, Romania; 8Multidisciplinary Research Center on Antimicrobial Resistance, ‘Victor Babes’ University of Medicine and Pharmacy, Timisoara, Romania; 9Department of Microbiology, ‘Victor Babes’ University of Medicine and Pharmacy, Timisoara, Romania; 10Clinical Laboratory, ‘Pius Brînzeu’ Emergency Clinical County Hospital, Timisoara, Romania; 11Department of Pharmacology, ‘Victor Babes’ University of Medicine and Pharmacy, Timisoara, Romania*These authors contributed equally to this workCorrespondence: Teodora Sorescu, Department of Diabetes, Nutrition and Metabolic Diseases, ‘Victor Babes’ University of Medicine and Pharmacy, 2 Eftimie Murgu Square, Timisoara, Romania, Tel +40724515424, Email sorescu.teodora@umft.roPurpose: Critically ill patients hospitalized in the intensive care unit (ICU) have an increased infection risk. …”
    Get full text
    Article
  15. 3975
  16. 3976
  17. 3977
  18. 3978
  19. 3979

    Bronchial Microbiota and the Stress Associated with Invasive Diagnostic Tests in Lung Cancer vs. Benign Pulmonary Diseases: A Cross-Sectional Study by Patricia Hogea, Emanuela Tudorache, Ovidiu Fira-Mladinescu, Camelia Pescaru, Diana Manolescu, Felix Bratosin, Ovidiu Rosca, Manaswini Kakarla, Florin George Horhat, Cristian Oancea

    Published 2023-07-01
    “…A cross-sectional study was conducted at the “Victor Babes” Hospital for Infectious Diseases and Pulmonology in Timisoara, Romania. A total of 33 patients with histologically diagnosed bronchopulmonary cancer and 33 control patients with benign lung pathologies underwent bronchoscopy. …”
    Get full text
    Article
  20. 3980